LEXIVA

LOE Approaching

fosamprenavir calcium

NDAORALSUSPENSIONPriority Review
Approved
Jun 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Clinical Trials (2)

NCT01010399Phase 4Completed

Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

Started Sep 2009
36 enrolled
HypertriglyceridemiaHIV Infection
NCT00085943Phase 3Completed

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Started May 2004
866 enrolled
HIV InfectionInfection, Human Immunodeficiency Virus